Skip to main content
Log in

Adalimumab

Graves’ disease (first report) in an elderly patient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Van Lieshout AWT, Creemers MCW, Radstake TRDJ, Elving LD, van Riel PLCM.Graves’ disease in a patient with rheumatoid arthritis during treatment with anti-tumor necrosis factor-alpha. The Journal of Rheumatology 35: 938-939, No. 5, Mar-Apr 2008 - Netherlands

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab. React. Wkly. 1202, 5 (2008). https://doi.org/10.2165/00128415-200812020-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812020-00012

Keywords

Navigation